Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GILD – Gilead Sciences, Inc.

Float Short %

1.61

Margin Of Safety %

26

Put/Call OI Ratio

0.74

EPS Next Q Diff

0.11

EPS Last/This Y

7.71

EPS This/Next Y

0.49

Price

114.75

Target Price

125.74

Analyst Recom

1.68

Performance Q

7.52

Relative Volume

0.76

Beta

0.38

Ticker: GILD




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25GILD116.210.820.25197296
2025-07-28GILD113.030.830.79190314
2025-07-29GILD114.240.831.93193035
2025-07-30GILD114.760.830.89193934
2025-07-31GILD112.30.831.44195156
2025-08-01GILD113.20.840.81197777
2025-08-04GILD114.510.850.77194727
2025-08-05GILD112.480.852.67195240
2025-08-06GILD110.30.880.85198087
2025-08-07GILD110.350.890.70224049
2025-08-08GILD119.370.900.64245924
2025-08-11GILD120.510.840.51202321
2025-08-12GILD120.060.830.18205788
2025-08-13GILD120.140.790.43214447
2025-08-14GILD1190.790.16215602
2025-08-15GILD118.320.780.43217706
2025-08-18GILD117.990.770.50174007
2025-08-19GILD1180.760.22177603
2025-08-20GILD118.730.740.52182345
2025-08-21GILD116.060.740.44184740
2025-08-22GILD114.710.740.20187870
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25GILD116.20-2.85555.67.98
2025-07-28GILD113.10-2.74935.48.00
2025-07-29GILD114.23-2.65370.68.00
2025-07-30GILD114.76-2.65301.18.00
2025-07-31GILD112.29-2.64996.08.00
2025-08-01GILD113.18-2.65339.18.00
2025-08-04GILD114.51-2.65383.88.00
2025-08-05GILD112.46-2.65038.48.00
2025-08-06GILD110.30-2.65023.48.00
2025-08-07GILD110.28-2.65286.38.00
2025-08-08GILD119.41-2.66243.88.00
2025-08-11GILD120.53-2.64997.28.00
2025-08-12GILD120.075.54850.68.07
2025-08-13GILD120.145.64900.58.07
2025-08-14GILD119.025.64781.28.07
2025-08-15GILD118.315.94820.18.08
2025-08-18GILD118.005.94944.98.08
2025-08-19GILD117.985.94970.48.08
2025-08-20GILD118.715.95053.08.08
2025-08-21GILD116.166.04729.68.09
2025-08-22GILD114.756.04842.58.09
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25GILD-15.740.871.81
2025-07-28GILD-15.740.231.81
2025-07-29GILD-16.100.231.81
2025-07-30GILD-16.100.231.81
2025-07-31GILD-16.100.231.81
2025-08-01GILD-16.100.231.81
2025-08-04GILD-10.750.311.81
2025-08-05GILD-10.750.311.81
2025-08-06GILD-10.750.311.81
2025-08-07GILD-10.750.311.81
2025-08-08GILD-10.750.311.81
2025-08-11GILD-10.770.341.82
2025-08-12GILD-10.770.341.61
2025-08-13GILD-10.770.341.61
2025-08-14GILD-4.880.341.61
2025-08-15GILD-4.880.341.61
2025-08-18GILD-4.88-0.101.61
2025-08-19GILD-6.25-0.101.61
2025-08-20GILD-4.98-0.101.61
2025-08-21GILD-4.98-0.101.61
2025-08-22GILD-4.98-0.101.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

2.01

Avg. EPS Est. Current Quarter

2.14

Avg. EPS Est. Next Quarter

2.12

Insider Transactions

-4.98

Institutional Transactions

-0.1

Beta

0.38

Average Sales Estimate Current Quarter

7389

Average Sales Estimate Next Quarter

7582

Fair Value

144.33

Quality Score

93

Growth Score

82

Sentiment Score

41

Actual DrawDown %

5.8

Max Drawdown 5-Year %

-26.6

Target Price

125.74

P/E

22.83

Forward P/E

13.31

PEG

0.86

P/S

4.94

P/B

7.25

P/Free Cash Flow

15.2

EPS

5.03

Average EPS Est. Cur. Y​

8.09

EPS Next Y. (Est.)

8.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

21.91

Relative Volume

0.76

Return on Equity vs Sector %

7.4

Return on Equity vs Industry %

-1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.1

EBIT Estimation

4842.5
Gilead Sciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 17600
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
stock quote shares GILD – Gilead Sciences, Inc. Stock Price stock today
news today GILD – Gilead Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GILD – Gilead Sciences, Inc. yahoo finance google finance
stock history GILD – Gilead Sciences, Inc. invest stock market
stock prices GILD premarket after hours
ticker GILD fair value insiders trading